Content about JERUSALEM

August 8, 2011

The Food and Drug Administration has accepted an approval application for a drug made by Teva Pharmaceutical Industries for treating allergies, Teva said.

July 29, 2011

Teva Pharmaceuticals has launched an authorized generic version of a contraceptive made by Duramed Pharmaceuticals, Teva said.

June 14, 2011

Before they can move ahead with their deal, drug makers Teva and Cephalon must provide the Federal Trade Commission with additional information related to Teva's pending acquisition of Cephalon.

June 2, 2011

The Food and Drug Administration has approved a generic drug for Alzheimer’s disease made by Teva Pharmaceutical Industries.

May 2, 2011

Cephalon has another suitor in the form of the world’s largest generic drug company.

April 12, 2011

An investigational drug made by Teva Pharmaceutical Industries and Active Biotech for multiple sclerosis reduced disease relapses and prevented the progression of disability, according to late-stage clinical trial results announced Monday.

March 1, 2011

Teva on Tuesday said that a trial date has been set for its ongoing patent infringement litigation against several drug makers.

February 9, 2011

An investigational drug made by Teva Pharmaceutical Industries for treating allergies is safe and effective, according to results of a late-stage clinical trial announced Wednesday.

February 8, 2011

Drug maker Teva on Tuesday said its North American sales during the fourth quarter ended Dec. 31 drove the drug maker's financial well-being.

January 26, 2011

Generic drug makers Teva Pharmaceutical Industries and APP Pharmaceuticals have launched their version of a chemotherapy drug, the two companies said Wednesday.

January 25, 2011

Teva on Tuesday confirmed its receipt of an action letter from the Food and Drug Administration for its generic blood-thinning drug.

December 13, 2010

Teva Pharmaceutical Industries has filed a citizen petition with the Food and Drug Administration, hoping to keep purported generic versions of its multiple sclerosis treatment off the market, the company said Sunday.

December 2, 2010

Oramed Pharmaceuticals, a developer of oral drug delivery solutions, has published an article in the Journal of Diabetes Science and Technology’s November issue describing evaluation of the company’s glucagon-like peptide (GLP-1) analog formulation (ORMD-0901) in regulating glucose excursions in animal models.

November 15, 2010

An investigative treatment for allergies made by Teva Pharmaceutical Industries appears to work, according to...

October 17, 2010

The Food and Drug Administration granted approval for Teva's abbreviated new drug application to market...

September 30, 2010

Teva Pharmaceutical Industries and Active Biotech announced promising results from a mid-stage trial of laquinimod,...

September 29, 2010

The Food and Drug Administration declined to approve a Teva biosimilar, the generic drug maker...

September 21, 2010

Teva filed a complaint against a generic drug maker this week, asserting four patents for...

September 14, 2010

Oramed Pharmaceuticals has seen promising results from a clinical trial of an oral insulin for...

August 9, 2010

Israeli drug maker Teva Pharmaceutical Industries has finished its $5 billion acquisition of German generic...

August 2, 2010

Teva Pharmaceutical Industries got closer to finishing its $5 billion acquisition of German drug maker...

© 2014 Drug Store News. All Rights Reserved.